DR Reddys officer reports 75,624 shares owned

DR REDDYS LABORATORIES LTD executive Deepak Sapra has filed an initial Form 3 reporting his equity holdings.

Accepted by SEC EDGAR 04/01/2026 - 09:38 AM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

DR REDDYS LABORATORIES LTD executive Deepak Sapra has filed an initial Form 3 reporting his equity holdings. As CEO - API and Services, he reports beneficial ownership of 75,624 equity shares held directly. This filing lists his position as of the reporting date and does not show any recent buy or sell transaction.

Insider Trade Summary

Holdings reported, no transactions

Holdings

Insider SAPRA DEEPAK

Role CEO - API and Services

Type	Security	Shares	Price	Value
Holding	Equity shares	--	--	--

Holdings: Equity shares — 75,624 shares (Direct)

Key Figures

Equity shares owned: 75,624 shares

1 metrics

Equity shares owned 75,624 shares Total equity shares beneficially owned following reported position

Key Terms

Form 3, Equity shares, beneficial ownership

3 terms

Form 3 regulatory

"INSIDER FILING DATA (Form 3):"

Form 3 is the initial public filing that officers, directors and large shareholders must submit to report their ownership of a company’s securities when they become insiders. It acts like an opening inventory sheet that gives investors a starting point to see who holds significant stakes and to spot later trades or potential conflicts of interest, helping assess insider confidence and transparency.

Equity shares financial

""security_title": "Equity shares""

Equity shares are units of ownership in a company that give the holder a claim on a portion of its assets and profits, like owning a slice of a business. They matter to investors because their value can rise or fall with the company’s performance and market sentiment, may provide periodic income through dividends, and often carry voting rights that influence how the business is run.

beneficial ownership financial

"initial statement of beneficial ownership, listing 75,624 equity shares"

Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does Deepak Sapra report in his DR REDDYS (RDY) Form 3 filing?

He reports beneficial ownership of 75,624 equity shares of DR REDDYS LABORATORIES LTD. This establishes his direct share position as CEO - API and Services, without indicating any recent purchase or sale activity in this specific filing.

Is Deepak Sapra buying or selling DR REDDYS (RDY) shares in this Form 3?

No, the Form 3 does not show any buy or sell transaction. It is an initial statement of beneficial ownership, listing 75,624 equity shares held directly, rather than reporting new trades in the company’s stock.

How many DR REDDYS (RDY) shares does Deepak Sapra beneficially own?

He beneficially owns 75,624 equity shares following the reported position. These shares are held directly, according to the Form 3, and represent his disclosed ownership stake as an officer of the company.

What is the role of Deepak Sapra at DR REDDYS (RDY) in this filing?

He is identified as an officer with the title "CEO - API and Services." The Form 3 links his executive role to a disclosed direct holding of 75,624 equity shares, providing transparency around his ownership stake.

Does the DR REDDYS (RDY) Form 3 show any derivative securities for Deepak Sapra?

No, the derivative section in the data is empty. The filing only lists equity shares, with 75,624 equity shares reported as directly owned, and does not show any options, warrants, or other derivative positions.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding Insider Trading Forms →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

SAPRA DEEPAK

(Last) (First) (Middle)

203, HANGING GARDEN,

MITHILA NAGAR, BANJARA HILLS

(Street)

HYDERABAD TELANGANA 500034

(City) (State) (Zip)

INDIA

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
12/18/2025

3. Issuer Name and Ticker or Trading Symbol
DR REDDYS LABORATORIES LTD [ RDY ]

3a. Foreign Trading Symbol
[DRREDDY&500124]

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	CEO - API and Services

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Equity shares	75,624	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

	/s/ DEEPAK SAPRA	04/01/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)